These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 22200840)

  • 1. Interval cancers after negative colonoscopy: population-based case-control study.
    Brenner H; Chang-Claude J; Seiler CM; Hoffmeister M
    Gut; 2012 Nov; 61(11):1576-82. PubMed ID: 22200840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CIMP status of interval colon cancers: another piece to the puzzle.
    Arain MA; Sawhney M; Sheikh S; Anway R; Thyagarajan B; Bond JH; Shaukat A
    Am J Gastroenterol; 2010 May; 105(5):1189-95. PubMed ID: 20010923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site.
    Steele RJ; McClements P; Watling C; Libby G; Weller D; Brewster DH; Black R; Carey FA; Fraser CG
    Gut; 2012 Apr; 61(4):576-81. PubMed ID: 21930729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study.
    Brenner H; Hoffmeister M; Arndt V; Stegmaier C; Altenhofen L; Haug U
    J Natl Cancer Inst; 2010 Jan; 102(2):89-95. PubMed ID: 20042716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low risk of colorectal cancer and advanced adenomas more than 10 years after negative colonoscopy.
    Brenner H; Haug U; Arndt V; Stegmaier C; Altenhofen L; Hoffmeister M
    Gastroenterology; 2010 Mar; 138(3):870-6. PubMed ID: 19909750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term risk of colorectal cancer after negative colonoscopy.
    Brenner H; Chang-Claude J; Seiler CM; Hoffmeister M
    J Clin Oncol; 2011 Oct; 29(28):3761-7. PubMed ID: 21876077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology.
    Bampton PA; Sandford JJ; Cole SR; Smith A; Morcom J; Cadd B; Young GP
    Gut; 2005 Jun; 54(6):803-6. PubMed ID: 15888788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of repeated screening using the fecal occult blood test and its impact on reducing false-negative cancer cases.
    Nishida H; Urano S
    Eur J Cancer Prev; 2011 May; 20(3):184-9. PubMed ID: 21301345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does a negative screening colonoscopy ever need to be repeated?
    Brenner H; Chang-Claude J; Seiler CM; Stürmer T; Hoffmeister M
    Gut; 2006 Aug; 55(8):1145-50. PubMed ID: 16469791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy.
    Brenner H; Chang-Claude J; Jansen L; Knebel P; Stock C; Hoffmeister M
    Gastroenterology; 2014 Mar; 146(3):709-17. PubMed ID: 24012982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of colorectal cancer after negative colonoscopy: a population-based study.
    Singh H; Nugent Z; Mahmud SM; Demers AA; Bernstein CN
    Am J Gastroenterol; 2010 Mar; 105(3):663-73; quiz 674. PubMed ID: 19904239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matching of controls may lead to biased estimates of specificity in the evaluation of cancer screening tests.
    Brenner H; Altenhofen L; Tao S
    J Clin Epidemiol; 2013 Feb; 66(2):202-8. PubMed ID: 23257151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
    Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric cancer after positive screening faecal occult blood testing and negative assessment.
    Zappa M; Visioli CB; Ciatto S; Grazzini G; Rubeca T; Bonanomi AG; Confortini M; Paci E; Castiglione G
    Dig Liver Dis; 2007 Apr; 39(4):321-6. PubMed ID: 17314076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early detection of colorectal cancer with faecal occult blood test screening.
    Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H
    Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. False-positive results from colorectal cancer screening in Catalonia (Spain), 2000-2010.
    Garcia M; Milà N; Binefa G; Borràs JM; Espinàs JA; Moreno V
    J Med Screen; 2012 Jun; 19(2):77-82. PubMed ID: 22653571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study.
    Faivre J; Tazi MA; El Mrini T; Lejeune C; Benhamiche AM; Dassonville F
    Br J Cancer; 1999 Feb; 79(3-4):680-3. PubMed ID: 10027349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
    Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colonoscopic screening of first-degree relatives of patients with large adenomas: increased risk of colorectal tumors.
    Cottet V; Pariente A; Nalet B; Lafon J; Milan C; Olschwang S; Bonaiti-Pellié C; Faivre J; Bonithon-Kopp C;
    Gastroenterology; 2007 Oct; 133(4):1086-92. PubMed ID: 17919484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection from colorectal cancer after colonoscopy: a population-based, case-control study.
    Brenner H; Chang-Claude J; Seiler CM; Rickert A; Hoffmeister M
    Ann Intern Med; 2011 Jan; 154(1):22-30. PubMed ID: 21200035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.